arrow
返回
M

Masato Nakamura

aizawa hospital

52H指数
684论文数
1.1W被引数
收录论文 159
发表时间
MVI-targeted Carbon-ion Radiotherapy Combined with Immunotherapy for Advanced Hepatocellular Carcinoma: Phase Ib DEPARTURE Trial
err2026-02-05
err0
errOAAI
errSadahisa Ogasawara; Keisuke Koroki; Hirokazu Makishima; Masaru Wakatsuki; Asahi Takahashi; Makoto Fujiya; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Shingo Nakamoto; Tomoya Kurokawa; Yoshihito Ozawa; Yosuke Inaba; Soumith Paritala; Jingxuan Chen
err分享
err收藏
3-Year Results Following Femoropopliteal Lesion Treatment With a Novel Sirolimus-Eluting Balloon使用新型西罗莫司洗脱球囊治疗股腘动脉病变的3年结果
err2025-11-10
err0
PREAI
errYoshimitsu Soga; Osamu Iida; Shigeru Saito; Toshiaki Mano; Naoki Hayakawa; Shigeo Ichihashi; Daizo Kawasaki; Kenji Suzuki; Terutoshi Yamaoka; Masahiko Fujihara; Tatsuya Nakama; Masato Nakamura; Kazunori Horie; Amane Kozuki
err分享
err收藏
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系
err2025-10-01
err0
errOAAI
errHiroaki Kanzaki; Takamasa Ishino; Sadahisa Ogasawara; Takahiro Tsuchiya; Makoto Fujiya; Midori Sawada; Ryo Izai; Teppei Akatsuka; Chihiro Miwa; Takuya Yonemoto; Sae Yumita; Miyuki Nakagawa; Ryuta Kojima; Keisuke Koroki; Masanori Inoue; Kazufumi Kobayashi; Naoya Kanogawa; Masato Nakamura; Takayuki Kondo; Shingo Nakamoto; Tsukasa Takayashiki; Yuka Takano; Kaho Takata; Jason Lin; Masahito Kawazu; Jun-ichiro Ikeda; Masayuki Ohtsuka; Yujin Hoshida; Mina Komuta; Yosuke Togashi
err分享
err收藏
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma随机对照II期研究,比较regorafenib两种剂量在晚期肝细胞癌二线治疗中的应用。
err2025-07-11
err0
errOAAI
errKeisuke Koroki; Sadahisa Ogasawara; Sae Yumita; Miyuki Nakagawa; Hiroaki Kanzaki; Kazufumi Kobayashi; Masanori Inoue; Masato Nakamura; Naoya Kanogawa; Takayuki Kondo; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Yuki Shiko; Yoshihito Ozawa; Yosuke Inaba
err分享
err收藏
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
err2025-02-01
err0
PREAI
errQiang, Na; Ao, Junjie; Nakamura, Masato; Katayama, Keichi; Zhang, Jiaqi; Kogure, Tadayoshi; Ogawa, Keita; Kanzaki, Hiroaki; Kojima, Ryuta; Koroki, Keisuke; Kobayashi, Kazufumi; Inoue, Masanori; Kanogawa, Naoya; Kiyono, Soichiro; Nakagawa, Ryo; Kondo, Takayuki; Ogasawara, Sadahisa; Nakamoto, Shingo; Muroyama, Ryosuke; Kato, Jun; Kato, Naoya
err分享
err收藏
Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701)
err2024-11-09
err0
PREAI
errKimura, Yutaka; Sugimoto, Naotoshi; Endo, Shunji; Kawabata, Ryohei; Matsuyama, Jin; Takeno, Atsushi; Nakamura, Masato; Takeshita, Hiroki; Satake, Hironaga; Tamura, Shigeyuki; Sakai, Daisuke; Kawakami, Hisato; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh
err分享
err收藏
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis
err2024-10-01
err0
PREAI
errAo, Junjie; Qiang, Na; Kanzaki, Hiroaki; Nakamura, Masato; Kakiuchi, Risa; Zhang, Jiaqi; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kanogawa, Naoya; Nakagawa, Ryo; Kondo, Takayuki; Ogasawara, Sadahisa; Nakamoto, Shingo; Muroyama, Ryosuke; Kato, Jun; Kato, Naoya
err分享
err收藏
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
err2024-06-06
err0
errOAAI
errKobayashi, Kazufumi; Ogasawara, Sadahisa; Itobayashi, Ei; Okubo, Tomomi; Itokawa, Norio; Nakamura, Kazuyoshi; Moriguchi, Michihisa; Watanabe, Shunji; Ikeda, Masafumi; Kuroda, Hidekatsu; Kawaoka, Tomokazu; Hiraoka, Atsushi; Yasui, Yutaka; Kuzuya, Teiji; Sato, Rui; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kiyono, Soichiro; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Ozawa, Yoshihito; Tsuchiya, Kaoru; Atsukawa, Masanori; Aikata, Hiroshi; Aramaki, Takeshi; Oka, Shiro; Morimoto, Naoki; Kurosaki, Masayuki; Itoh, Yoshito; Izumi, Namiki; Kato, Naoya
err分享
err收藏
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
err2024-05-21
err0
errOAAI
errInoue, Masanori; Ogasawara, Sadahisa; Kobayashi, Kazufumi; Okubo, Tomomi; Itokawa, Norio; Obu, Masamichi; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Fujiwara, Kisako; Nakagawa, Miyuki; Kanzaki, Hiroaki; Koroki, Keisuke; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nagashima, Kengo; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Naoya
err分享
err收藏
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma
err2024-04-07
err1
errOAAI
errFujiwara, Kisako; Kondo, Takayuki; Fujimoto, Kentaro; Yumita, Sae; Ogawa, Keita; Ishino, Takamasa; Nakagawa, Miyuki; Iwanaga, Terunao; Tsuchiya, Satoshi; Koroki, Keisuke; Kanzaki, Hiroaki; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Ogasawara, Sadahisa; Nakamoto, Shingo; Chiba, Tetsuhiro; Koizumi, Jun; Kato, Jun; Kato, Naoya
err分享
err收藏
Exploring the efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
err2024-03-22
err0
PREAI
errKanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Kiyono, Soichiro; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Lin, Jason; Kawazu, Masahito; Komuta, Mina; Ikeda, Jun-ichiro; Ohtsuka, Masayuki; Togashi, Yosuke; Kato, Naoya
err分享
err收藏
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer在TRUSTY研究中使用血浆血管生成相关因子和无细胞DNA进行探索性生物标志物分析: 一项关于三氟尿苷/替匹拉西加贝伐单抗作为转移性结直肠癌二线治疗的随机II/III期研究
err2024-01-09
err4
errOAAI
errSunakawa, Yu; Kuboki, Yasutoshi; Watanabe, Jun; Terazawa, Tetsuji; Kawakami, Hisato; Yokota, Mitsuru; Nakamura, Masato; Kotaka, Masahito; Sugimoto, Naotoshi; Ojima, Hitoshi; Oki, Eiji; Kajiwara, Takeshi; Yamamoto, Yoshiyuki; Tsuji, Yasushi; Denda, Tadamichi; Tamura, Takao; Ishihara, Soichiro; Taniguchi, Hiroya; Nakajima, Takako Eguchi; Morita, Satoshi; Shirao, Kuniaki; Takenaka, Naruhito; Ozawa, Daisuke; Yoshino, Takayuki
err分享
err收藏
Survival analysis of m-FOLFOXIRI plus cetuximab vs. bevacizumab in RAS wild-type mCRC: The DEEPER trial (JACCRO CC-13)
err2023-11-01
err0
errOAAI
errTsuji, Akihito; Endo, Izuru; Kobayashi, Kenji; Miyamoto, Yuji; Kusumoto, Tetsuya; Yuasa, Yasuhiro; Miwa, Keisuke; Kochi, Mitsugu; Sagawa, Tamotsu; Kotaka, Masahito; Kubota, Yutaro; Sunakawa, Yu; Sekikawa, Takashi; Nakamura, Masato; Takeuchi, Masahiro; Ichikawa, Wataru; Fujii, Masashi
err分享
err收藏
Retrospective study of comprehensive cancer genomic profile (CGP) testing for pancreatic cancer
err2023-11-01
err0
errOAAI
errNomura, Mitsutoshi; Kimura, Junko; Nakamura, Masato; Sugii, Kinuko; Simojou, Hisashi; Tsukahara, Mika; Moteki, Hideaki
err分享
err收藏
An update analysis of the JACCRO CC-16: Ramucirumab plus FOLFIRI for RAS wild-type mCRC refractory to anti-EGFR antibody
err2023-11-01
err0
errOAAI
errManaka, Dai; Tsuji, Akihito; Shibutani, Masatsune; Ishibashi, Keiichiro; Yabuno, Taichi; Okamura, Shu; Furuya, Takumi; Tanaka, Chihiro; Nakamura, Masato; Sagawa, Tamotsu; Watanabe, Takanori; Shiozawa, Manabu; Sunakawa, Yu; Ota, Hirofumi; Kotaka, Masahito; Okuyama, Hiroyuki; Okita, Yoshihiro; Ichikawa, Wataru; Fujii, Masashi
err分享
err收藏
A prospective study of circulating tumor DNA (ctDNA) genomic profiling in gastric or gastroesophageal junction (GEJ) cancer patients with recurrence after adjuvant chemotherapy: Liquid-GEAR trial
err2023-10-01
err0
errOAAI
errTakeda, H.; Kawabata, R.; Ishiguro, A.; Nishina, S.; Takahashi, M.; Suzuki, S.; Suzuki, T.; Matsuyama, J.; Okita, A.; Miyagaki, H.; Takegawa, N.; Nomura, T.; Kito, Y.; Yabusaki, H.; Negoro, Y.; Makiyama, A.; Nakamura, M.; Takahashi, M.; Sunakawa, Y.
err分享
err收藏
Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16
err2023-10-01
err2
errOAAI
errYasui, H.; Okita, Y.; Nakamura, M.; Sagawa, T.; Watanabe, T.; Kataoka, K.; Manaka, D.; Shiraishi, K.; Akazawa, N.; Okuno, T.; Shimura, T.; Shiozawa, M.; Sunakawa, Y.; Ota, H.; Kotaka, M.; Okuyama, H.; Takeuchi, M.; Ichikawa, W.; Fujii, M.; Tsuji, A.
err分享
err收藏